What is the recommended dosage of niacin (vitamin B3) for treating deficiency and for lipid‑lowering therapy in adults?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 25, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Niacin Dosing Recommendations

For nutritional supplementation, use 14-16 mg/day for adults; for lipid-lowering therapy, start extended-release niacin at 500 mg/day and titrate to a maximum of 2,000 mg/day over 4-8 weeks, or start immediate-release niacin at 100 mg three times daily and titrate to 3 g/day divided into 2-3 doses. 1

Nutritional Supplementation Doses

Standard Daily Requirements

  • Adult males (>14 years): 16 mg/day 2, 3
  • Adult females (>14 years): 14 mg/day 2, 3
  • Pregnant women: 18 mg/day 2, 3
  • Lactating women: 17 mg/day 3
  • Upper tolerable limit: 35 mg/day to avoid flushing and adverse effects 3

Clinical Nutrition Settings

  • Enteral nutrition: 18-40 mg per day in 1500 kcal 1, 3
  • Parenteral nutrition: 40 mg per day minimum 1, 2, 3

Therapeutic Lipid-Lowering Doses

Extended-Release Niacin (Preferred for Tolerability)

  • Starting dose: 500 mg/day 1
  • Titration schedule: Increase by no more than 500 mg weekly over 4-8 weeks 1
  • Maximum dose: 2,000 mg/day 1

Immediate-Release Niacin

  • Starting dose: 100 mg three times daily 1
  • Target dose: Up to 3 g/day divided into 2-3 doses 1

Pellagra Treatment (Niacin Deficiency)

  • Nicotinic acid: 15-20 mg/day 1
  • Nicotinamide: 300 mg/day 1, 2

Critical Safety Monitoring Requirements

Before initiating therapeutic doses, obtain baseline hepatic transaminases, fasting blood glucose or hemoglobin A1c, and uric acid levels; repeat during dose titration and every 6 months thereafter. 1, 3

Absolute Contraindications to Niacin Use

  • Hepatic transaminase elevations >2-3 times upper limit of normal 1, 3
  • Active liver disease or unexplained hepatic dysfunction 3
  • Persistent severe cutaneous symptoms 1
  • Persistent hyperglycemia 1
  • Acute gout 1
  • Unexplained abdominal pain or gastrointestinal symptoms 1
  • New-onset atrial fibrillation or unexplained weight loss 1

Flushing Management Strategies

The ACC/AHA guidelines provide specific strategies to reduce the frequency and severity of cutaneous flushing, which is the most common reason for niacin discontinuation: 1

  • Start low and titrate slowly over weeks as tolerated 1
  • Take with food to reduce flushing intensity 1, 3
  • Premedicate with aspirin 325 mg taken 30 minutes before niacin dosing 1, 3
  • Use extended-release formulations rather than immediate-release when possible 1

Important Clinical Caveats

Prescription vs. Over-the-Counter Products

Only use FDA-approved prescription niacin products (Niacor, Niaspan) for lipid-lowering therapy; dietary supplement niacin should not be substituted for prescription niacin. 1, 4 Over-the-counter "no-flush" or "flush-free" niacin products contain minimal pharmacologically active niacin and lack lipid-modifying effects. 4

Form-Specific Considerations

  • Nicotinic acid causes flushing at doses as low as 30 mg 1, 3
  • Nicotinamide does not cause flushing but also lacks lipid-lowering effects at nutritional doses 1, 2
  • Upper safety limit for nicotinic acid: 10 mg/day for free nicotinic acid 2
  • Upper safety limit for nicotinamide: approximately 900 mg/day for adults 2, 3

Special Population Considerations

  • Diabetic patients: Can safely use niacin at doses ≤2.5 g/day with only modest effects on glucose control 3
  • Statin-treated patients: The ACC/AHA recommends against routine use of pharmacological niacin doses (500-2000 mg/day) in statin-treated patients, as recent trials showed no additional cardiovascular benefit 3
  • Elderly on calorie-restricted diets: May require supplementation to meet basic nutritional needs 3

Hepatotoxicity Risk

Niacin-associated hepatotoxicity generally occurs at doses around 3 g per day, ranging from mild liver enzyme elevation to acute liver failure. 1 Monitor hepatic transaminases every 6 months and discontinue immediately if levels exceed 2-3 times upper limit of normal. 1, 3

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

NAD+ Supplementation Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Vitamin B3 (Niacin) Intake and Therapeutic Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.